The sequential therapy regimen for Helicobacter pylori eradication: A pooled-data analysis

Gut

Volumn 56, Issue 10, 2007, Pages 1353-1357

  Zullo, Angelo ^b   De Francesco, Vincenzo ^c   Hassan, Cesare ^b   Morini, Sergio ^b   Vaira, Dino ^a,d  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b NUOVO REGINA MARGHERITA HOSPITAL   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d Riuniti Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CLARITHROMYCIN; ESOMEPRAZOLE; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RABEPRAZOLE; TINIDAZOLE;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; DATA ANALYSIS; DIARRHEA; DRUG COST; DRUG DOSE SEQUENCE; DRUG EFFICACY; DYSPEPSIA; EPIGASTRIC PAIN; FEMALE; GERIATRIC PATIENT; GLOSSITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PEPTIC ULCER; PRIORITY JOURNAL; PRURITUS; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; VOMITING;

ADOLESCENT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PROTON PUMPS; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 34948911342     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2007.125658     Document Type: Article

References (75)

1. Malfertheiner P, Mégraud F, O'Morain CA, et al. Current concepts in the management of Helicobacter pylori infection. The Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 2002;16:167-80.
2. Maconi G, Tosetti C, Miroglio G, et al. Management of Helicobacter pylori-related gastrointestinal diseases by general practitioners in Italy. Aliment Pharmacol Ther 1999;13:1499-504.
3. Delia Monica P, Lavagna A, Masoero G, et al. Effectiveness of Helicobacter pylori eradication treatments in a primary care setting in Italy. Aliment Pharmacol Ther 2002;16:1269-75.
4. Sharma VK, Howden CW. A national survey of primary care physicians' perceptions and practices related to Helicobater pylori infection. J Clin Gastroenterol 2004;38:326-31.
5. Shirin H, Birkenfeld S, Shevah O, et al. Application of Maastricht 2-2000 guidelines for the management of Helicobacter pylori among specialists and primary care physicians in Israel: are we missing the malignant potential of Helicobacter pylori? J Clin Gastroenterol 2004;38:322-5.
6. Zullo A, De Francesco V, Scaccianoce G, et al. Quadruple therapy with lactoferrin for Helicobacter pylori eradication: a randomized, multicenter study. Dig Liver Dis 2005;37:496-500.
7. Hawkey CJ, Atherton JC, Treichel HC, et al. Safety and efficacy of 7-day rabeprazole- and omeprazole-based triple therapy regimens for eradication of Helicobacter pylori in patients with documented peptic disease. Aliment Pharmacol Ther 2003;17:1065-74.
8. Kashimura H, Suzuki K, Hassan M, et al. Polaprezinc, a mucosal protective agent, in combination with lansoprazole, amoxicillin and clarithromycin increases the cure rate of Helicobacter pylori infection. Aliment Pharmacol Ther 1999;13:483-7.
9. Wong BCY, Chang FY, Abid S, et al. Triple therapy with clarithromycin, omeprazole, and amoxicillin for eradication of Helicobacter pylori in duodenal ulcer patients in Asia and Africa. Aliment Pharmacol Ther 2000;14:1529-35.
10. Laine L, Fennerty MB, Osato M, et al. Esomeprazole-based Helicobacter pylori eradication therapy and the effect of antibiotic resistance: results of three US multicenter, double-blind trials. Am J Gastroenterol 2000;95:3393-8.
11. Vakil N, Cutler A. Ten-day triple therapy with ranitidine bismuth citrate, amoxicillin, and clarithromycin in eradicating Helicobacter pylori. Am J Gastroenterol 1999;94:1197-9.
12. Veldhuyzen van Zanten S, Machado S, Lee J. One-week triple therapy with esomeprazole, clarithromycin and metronidazole provides effective eradication of Helicobacter pylori infection. Aliment Pharmacol Ther 2003;17:1381-7.
13. Altintas E, Sezgin O, Ulu O, et al. Maastricht II treatment scheme and efficacy of different proton pump inhibitors in eradicating Helicobacter pylori. World J Gastroenterol 2004;10:1656-8.
14. Gumurdulu Y, Serin E, Ozer B, et al. Low eradication rate of Helicobacter pylori with triple 7-14 days and quadruple therapy in Turkey. World J Gastroenterol 2004;10:668-71.
15. Megraud F. H. pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut 2004;53:1374-84.
16. Malfertheiner P, Megraud F, O'Morain C, et al. Current concepts in the management of Helicobacter pylori infection - The Maastricht III Consensus Report. Gut 2007;56:772-81.
17. Calvet X, Garcia N, Lopez T, et al. A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxicillin for treating Helicobacter pylori infection. Aliment Pharmacol Ther 2000;14:603-8.
18. Zagari RM, Bianchi-Porro G, Fiocca R, et al. Comparison of one and two weeks of omeprazole, amoxicillin and clarithromycin treatment for Helicobacter pylori eradication: the HYPER study. Gut 2007;56:475-9.
19. Paoluzi P, Iacopini F, Crispino P, et al. 2-week triple therapy for Helicobacter pylori infection is better than 1-week in clinical practice: a large prospective single-center randomized study. Helicobacter 2006;11:562-8.
20. Genè E, Calvet X, Azagra R, et al. Triple vs. quadruple therapy for treating Helicobacter pylori infection: an updated meta-analysis. Aliment Pharmacol Ther 2003;18:543-4.
21. Huang J-Q, Hunt RH. Treatment after failure: the problem of "non-responders". Gut 1999;45:140-44.
22. Zullo A, Rinaldi V, Winn S, et al. A new highly effective short-term therapy schedule for Helicobacter pylori eradication. Aliment Pharmacol Ther 2000;14:715-8.
23. Rinaldi V, Zullo A, Pugliano F, et al. The management of failed dual or triple therapy for Helicobacter pylori eradication. Aliment Pharmacol Ther 1997;11:929-33.
24. Unge P. Review of Helicobacter pylori eradication regimens. Scand J Gastroenterol, 1996;31(Suppl.215), 74-81.
25. Perri F, Clemente R, Festa V, et al. Relationship between the results of pre-treatment urea breath test and efficacy of eradication of Helicobacter pylori. Ital J Gastroenterol Hepatol 1998;30:146-50.
26. Maconi G, Parente F, Russo A, et al. Do some patients with Helicobacter pylori infection benefit from an extension to 2 weeks of a proton pump inhibitor-based triple eradication therapy? Am J Gastroenterol 2001;96:359-66.
27. Lai YC, Yang JC, Huang SH. Pre-treatment urea breath test results predict the efficacy of Helicobacter pylori eradication therapy in patients with active duodenal ulcers. World J Gastroenterol 2004;10:991-4.
28. Murakami K, Fujioka T, Okimoto T, et al. Drug combinations with amoxicillin reduces selection of clarithromycin resistance during Helicobacter pylori eradication therapy. Int J Antimicrob Agents 2002;19:67-70.
29. Paulsen IT, Brown MH, Skurray RA. Proton-dependent multidrug efflux systems. Microbiol Rev 1996;60:575-608.
30. Webber MA, Piddock U. The importance of efflux pumps in bacterial antibiotic resistance. J Antimicrob Chemother 2003;51:9-11.
31. Roberts MC. Resistance to macrolide, lincosamide, streptogramin, ketolide, and oxazolidinone antibiotics. Mol Biotechnol 2004;28:47-62.
32. De Francesco V, Zullo A, Hassan C, et al. Two new treatment regimens for Helicobacter pylori eradication: a randomised study. Dig Liver Dis 2001;33:67-9.
33. Focareta R, Forte G, Ciarleglio A, et al. Helicobacter pylori eradication: one week triple therapy vs. 10-day sequential regimen. Dig Liver Dis, 2002;34(Suppl 1), A17.
34. Zullo A, Vaira D, Vakil N, et al. High eradication rates of Helicobacter pylori with a new sequential treatment. Aliment Pharmacol Ther 2003;17:719-6.
35. Hassan C, De Francesco V, Zullo A, et al. Sequential treatment for Helicobacter pylori eradication in duodenal ulcer patients: improving the cost of pharmacotherapy. Aliment Pharmacol Ther 2003;18:641-6.
36. Focareta R, Forte G, Forte F, et al. Could the 10-days sequential therapy be considered a first choice treatment for the eradication of Helicobacter pylori infection? Dig Liver Dis, 2003;35(Suppl 4), S33.
37. De Francesco V, Delia Valle N, Stoppino V, et al. Effectiveness and pharmaceutical cost of sequential treatment for Helicobacter pylori in patients with non-ulcer dyspepsia. Aliment Pharmacol Ther 2004;19:993-8.
38. De Francesco V, Zullo A, Margiotta M, et al. Sequential treatment for Helicobacter pylori infection does not share the risk factors of triple therapy failure. Aliment Pharmacol Ther 2004;19:407-14.
39. De Francesco V, Zullo A, Hassan C, et al. The prolongation of triple therapy for Helicobacter pylori does not allow reaching therapeutic outcome of sequential scheme: a prospective, randomized study. Dig Liver Dis 2004;36:322-6.
40. Francavilla R, Lionetti E, Castellaneta SP, et al. Improved efficacy of 10-day sequential treatment for Helicobacter pylori eradication in children: a randomized trial. Gastroenterology 2006;129:1414-9.
41. Zullo A, Gatta L, De Francesco V, et al. High Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer: a prospective controlled study. Aliment Pharmacol Ther 2005;22:1419-24.
42. Zullo A, Hassan C, Campo SMA. Elevata efficacia della terapia sequenziale nel trartamento dell'infezione da Helicobacter pylori. Ospedale e Territorio - Gastroenterologia 2004;5:87-90.
43. Scaccianoce G, Hassan C, Panarese A, et al. Helicobacter pylori eradication with either 7-day or 10-day triple therapies, and with 10-day sequential regimen. Can J Gastroenterol 2006;20:113-7.
44. Lionetti E, Miniello VL, Castellaneta SP, et al. Lactobacillus reuteri therapy to reduce side-effects during anti-Helicobacter pylori treatment in children: a randomized placebo controlled trial. Aliment Pharmacol Ther 2006;24:1461-8.
45. Vaira D, Zullo A, Vakil N, et al. Sequential therapy versus triple therapy for Helicobacter pylori eradication: a randomized trial. Ann Int Med 2007;146:556-63.
46. De Francesco V, Margiotta M, Zullo A, et al. Clarithromycin-resistant genotypes and eradication of Helicobacter pylori. Ann Int Med 2006;144:94-100.
47. Huang JQ, Zheng GF, Hunt RH, et al. Do patients with non-ulcer dyspepsia respond differently to Helicobacter pylori eradication treatments from those with peptic ulcer disease? A systematic review. World J Gastroenterol 2005;11:2726-32.
48. Oderda G, Marinello D, Lerro P, et al. Dual vs. triple therapy for childhood Helicobacter pylori gastritis: a double-blind randomized multicentre trial. Helicobacter 2004;9:293-301.
49. Gottrand F, Kalach N, Spyckerelle C, et al. Omeprazole combined with amoxicillin and clarithromycin in the eradication of Helicobacter pylori in children with gastritis: a prospective randomized double-blind trial. J Pediatr 2001;139:664-8.
50. Pilotto A, Leandro G, Franceschi M, et al. The effect of antibiotic resistance on the outcome of three 1-week triple therapies against Helicobacter pylori. Aliment Pharmacol Ther 1999;13:667-73.
51. Pilotto A, Di Mario F, Franceschi M, et al. Pantoprazole versus one-week Helicobacter pylori eradication therapy for the prevention of acute NSAID-related gastroduodenal damage in elderly subjects. Aliment Pharmacol Ther 2000;14:1077-82.
52. Pilotto A, Franceschi M, Leandro G, et al. Cure of Helicobacter pylori infection in elderly patients: comparison of low versus high doses of clarithromycin in combination with amoxicillin and pantoprazole. Aliment Pharmacol Ther 2001;15:1031-6.
53. Kamada T, Haruma K, Miyoshi E, et al. Cetraxate, a mucosal protective agent, combined with omeprazole, amoxicillin and clarithromycin increases the eradication rate of Helicobacter pylori in smokers. Aliment Pharmacol Ther 2000;14:1089-94.
54. Houben M, van de Beek D, Hensen E, et al. A systematic review of Helicobacter eradication therapy - the impact of antimicrobial resistance on eradication rates. Aliment Pharmacol Ther 1999;13:1047-55.
55. Vaira D, Gatta L, Ricci C, et al. Helicobacter pylori: diseases, tests and treatment. Dig Liver Dis 2001;33:788-94.
56. Toracchio S, Marzio L. Primary and secondary antibiotic resistance of Helicobacter pylori strains isolated in central Italy during the years 1998-2002. Dig Liver Dis 2003;35:541-5.
57. De Francesco V, Margiotta M, Zullo A, et al. Primary clarithromycin resistance in Italy assessed on Helicobacter pylori-DNA sequences by TaqMan real-time polymerase chain reaction. Aliment Pharmacol Ther 2006;23:429-35.
58. Delgado JS, Bujanda L, Gisbert JP, et al. Effectiveness of a 10-day sequential therapy treatment for Helicobacter pylori eradication in clinical practice. Gastroenterology, 2007;132(Suppl 2), A112.
59. Zullo A, Hassan C, De Francesco V, et al. A third-line levofloxacin-based rescue therapy for Helicobacter pylori eradication. Dig Liver Dis 2003;35:232-6.
60. Watanabe Y, Aoyama N, Shirasaka D, et al. Levofloxacin-based triple therapy as a second-line treatment after failure of Helicobacter pylori eradication with standard triple therapy. Dig Liver Dis 2003;35:711-5.
61. Gatta L, Zullo A, Perna F, et al. A 10-day levofloxacin-based triple therapy in patients who have failed two eradication courses. Aliment Pharmacol Ther 2005;22:45-9.
62. Gisbert JP, De La Morena F. Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure. Aliment Pharmacol Ther 2006;23:35-44.
63. Saad RJ, Schoenfeld P, Kim HM, et al. Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis. Am J Gastroenterol 2006;101:488-96.
64. Zullo A, De Francesco V, Hassan C, et al. Second-line treatment for Helicobacter pylori eradication after sequential therapy failure: a pilot study. Therapy 2006;3:251-4.
65. Koletzko S, Richy F, Bontems P, et al. Prospective multicentre study on antibiotic resistance of Helicobacter pylori strains obtained from children living in Europe. Gut 2006;55:1811-16.
66. Zullo A, Hassan C, Eramo A, et al. Helicobacter pylori therapy: what is coming? Expert Opin Ther Patents 2006;16:1107-12.
67. Francois F, Blaser MJ. Improving Helicobacter pylori eradication regimens. Ann Intern Med 2006;144:140-1.
68. El-Omar EM. What is the optimal therapy for the eradication of Helicobacter pylori? Nature Clin Pract Gastroenterol Hepatol 2006;3:126-7.
69. Bytzer P, O'Morain C. Treatment of Helicobacter pylori. Helicobacter 2005;10:40-6.
70. Chiba N. A sequential 10-day regimen was better than standard triple therapy for eradication of Helicobacter pylori. ACP Journal Club 2006;144:2.
71. Calvet X. Helicobacter pylori infection: treatment options. Digestion, 2206;73(Suppl 1), 119-28.
72. Kuipers EJ. Can Helicobacter pylori eradication therapy be shortened to 4 days? Nature Clin Pract Gastroenterol Hepatol 2007;4:68-9.
73. Cherry K. Eradication of childhood H pylori infection by a novel sequential treatment regimen. Nature Clin Pract Gastroenterol Hepatol 2006;3:64-5.
74. Morgner A, Labenz J, Miehlke S. Effective regimens for the treatment of Helicobacter pylori infection. Expert Opin Investig Drugs 2006;15:995-1016.
75. Caselli M, Zullo A, Maconi G, et al. Cervia II Working Group Report 2006: Guidelines on diagnosis and treatment of Helicobacter pylori infection. Dig Liver Dis 2007;39:782-9.